Stanford researchers have developed an R-spondin1-producing cell line. The cell line is a transfectant of 293T cells expressing mouse R-spondin1 protein tagged with N-terminus HA and C-terminus Fc.
Researchers in Prof. Michelle Monje-Deisseroth's laboratory have discovered a previously unknown mechanism for glioma tumor growth and invasion that defines a novel set of therapeutic targets.
Time-resolved phase contrast MRI (4D flow) can quantify cardiac function and flow. The technique may even permit complex anatomical assessment, thus comprising a comprehensive exam in a single scan. Unfortunately, artifacts from respiratory motion compromise this ability.
1D6 is a monoclonal antibody (mAb) which recognizes human CD81. It was identified by its ability to induce aggregation of a human lymphoma B cell line. This mAb is capable of inducing an antiproliferative effect in B cells
Stanford researchers have developed a cell line (MFB-F11) that can be used for an easy, sensitive, and specific bioassay to study the biological functions of Transforming Growth Factor-beta (TGF-beta).
Researchers in Dr. Dean Felsher's lab have generated a murine hepatocellular carcinoma (HCC) cell line with controllable MYC expression. HCC is one of the most common and incurable malignancies.
This portfolio of inventions provides the tools for an advanced navigational system and panoramic virtual tours – technology that is incorporated in Google Street View.
An optical device, a method of configuring an optical device, and a method of using a fiber Bragg grating is provided. The optical device includes a fiber Bragg grating, a narrowband optical source, and at least one optical detector.
An optical device includes at least one optical waveguide including a plurality of elongate portions. Light propagates sequentially and generally along the elongate portions.
Stanford engineers have created a patented method for fabricating highly sensitive piezoresistors on vertical walls of microstructures by epitaxial growth of doped silicon.
Although tracking has been studied for decades, real-time tracking algorithms often suffer from low accuracy and poor robustness when confronted with difficult, real-world data.
Stanford researchers have created a device with defined parallel-oriented fibrillar nanostructure that can control endothelial cell alignment along the direction of the fibrillar nanostructure.